The aggregation of high affinity IgE receptors (Fcε receptor I [FcεRI]) on mast cells is potent stimulus for the release of inflammatory and allergic mediators from cytoplasmic granules. However, the molecular mechanism of degranulation has not yet been established. It is still unclear how FcεRI-mediated signal transduction ultimately regulates the reorganization of the cytoskeleton and how these events lead to degranulation. Here, we show that FcεRI stimulation triggers the formation of microtubules in a manner independent of calcium. Drugs affecting microtubule dynamics effectively suppressed the FcεRI-mediated translocation of granules to the plasma membrane and degranulation. Furthermore, the translocation of granules to the plasma membrane occurred in a calcium-independent manner, but the release of mediators and granule–plasma membrane fusion were completely dependent on calcium. Thus, the degranulation process can be dissected into two events: the calcium-independent microtubule-dependent translocation of granules to the plasma membrane and calcium-dependent membrane fusion and exocytosis. Finally, we show that the Fyn/Gab2/RhoA (but not Lyn/SLP-76) signaling pathway plays a critical role in the calcium-independent microtubule-dependent pathway.
Skip Nav Destination
Article navigation
4 July 2005
Article Contents
Article|
July 05 2005
FcεRI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane
Keigo Nishida,
Keigo Nishida
1Laboratory for Cytokine Signaling, RIKEN Research Center for Allergy and Immunology (RCAI), Kanagawa 230-0045, Japan
2Laboratory of Developmental Immunology (C7), Graduate School of Medicine
Search for other works by this author on:
Satoru Yamasaki,
Satoru Yamasaki
1Laboratory for Cytokine Signaling, RIKEN Research Center for Allergy and Immunology (RCAI), Kanagawa 230-0045, Japan
Search for other works by this author on:
Yukitaka Ito,
Yukitaka Ito
1Laboratory for Cytokine Signaling, RIKEN Research Center for Allergy and Immunology (RCAI), Kanagawa 230-0045, Japan
3Laboratory of Developmental Immunology, Graduate School of Frontier Biosciences, Osaka University, Osaka 565-0871, Japan
Search for other works by this author on:
Koki Kabu,
Koki Kabu
1Laboratory for Cytokine Signaling, RIKEN Research Center for Allergy and Immunology (RCAI), Kanagawa 230-0045, Japan
2Laboratory of Developmental Immunology (C7), Graduate School of Medicine
Search for other works by this author on:
Kotaro Hattori,
Kotaro Hattori
4KOKORO-Biology Group and CREST, Graduate School of Frontier Biosciences, Osaka University, Osaka 565-0871, Japan
Search for other works by this author on:
Tohru Tezuka,
Tohru Tezuka
5Division of Oncology, Department of Cancer Biology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan
Search for other works by this author on:
Hirofumi Nishizumi,
Hirofumi Nishizumi
5Division of Oncology, Department of Cancer Biology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan
Search for other works by this author on:
Daisuke Kitamura,
Daisuke Kitamura
6Division of Molecular Biology, Research Institute for Biological Sciences, Tokyo University of Science, Chiba 278-0022, Japan
Search for other works by this author on:
Ryo Goitsuka,
Ryo Goitsuka
6Division of Molecular Biology, Research Institute for Biological Sciences, Tokyo University of Science, Chiba 278-0022, Japan
Search for other works by this author on:
Raif S. Geha,
Raif S. Geha
7Division of Immunology, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115
Search for other works by this author on:
Tadashi Yamamoto,
Tadashi Yamamoto
5Division of Oncology, Department of Cancer Biology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan
Search for other works by this author on:
Takeshi Yagi,
Takeshi Yagi
4KOKORO-Biology Group and CREST, Graduate School of Frontier Biosciences, Osaka University, Osaka 565-0871, Japan
Search for other works by this author on:
Toshio Hirano
Toshio Hirano
1Laboratory for Cytokine Signaling, RIKEN Research Center for Allergy and Immunology (RCAI), Kanagawa 230-0045, Japan
2Laboratory of Developmental Immunology (C7), Graduate School of Medicine
3Laboratory of Developmental Immunology, Graduate School of Frontier Biosciences, Osaka University, Osaka 565-0871, Japan
Search for other works by this author on:
Keigo Nishida
1Laboratory for Cytokine Signaling, RIKEN Research Center for Allergy and Immunology (RCAI), Kanagawa 230-0045, Japan
2Laboratory of Developmental Immunology (C7), Graduate School of Medicine
Satoru Yamasaki
1Laboratory for Cytokine Signaling, RIKEN Research Center for Allergy and Immunology (RCAI), Kanagawa 230-0045, Japan
Yukitaka Ito
1Laboratory for Cytokine Signaling, RIKEN Research Center for Allergy and Immunology (RCAI), Kanagawa 230-0045, Japan
3Laboratory of Developmental Immunology, Graduate School of Frontier Biosciences, Osaka University, Osaka 565-0871, Japan
Koki Kabu
1Laboratory for Cytokine Signaling, RIKEN Research Center for Allergy and Immunology (RCAI), Kanagawa 230-0045, Japan
2Laboratory of Developmental Immunology (C7), Graduate School of Medicine
Kotaro Hattori
4KOKORO-Biology Group and CREST, Graduate School of Frontier Biosciences, Osaka University, Osaka 565-0871, Japan
Tohru Tezuka
5Division of Oncology, Department of Cancer Biology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan
Hirofumi Nishizumi
5Division of Oncology, Department of Cancer Biology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan
Daisuke Kitamura
6Division of Molecular Biology, Research Institute for Biological Sciences, Tokyo University of Science, Chiba 278-0022, Japan
Ryo Goitsuka
6Division of Molecular Biology, Research Institute for Biological Sciences, Tokyo University of Science, Chiba 278-0022, Japan
Raif S. Geha
7Division of Immunology, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115
Tadashi Yamamoto
5Division of Oncology, Department of Cancer Biology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan
Takeshi Yagi
4KOKORO-Biology Group and CREST, Graduate School of Frontier Biosciences, Osaka University, Osaka 565-0871, Japan
Toshio Hirano
1Laboratory for Cytokine Signaling, RIKEN Research Center for Allergy and Immunology (RCAI), Kanagawa 230-0045, Japan
2Laboratory of Developmental Immunology (C7), Graduate School of Medicine
3Laboratory of Developmental Immunology, Graduate School of Frontier Biosciences, Osaka University, Osaka 565-0871, Japan
Correspondence to Toshio Hirano: [email protected]
K. Nishida and S. Yamasaki contributed equally to this paper.
Abbreviations used in this paper: BMMC, bone marrow–derived mast cell; FcεRI, Fcε receptor I; Gab2, Grb2-associated binder 2; LAT, linker for the activation of T cells; SLP-76, SH2 domain–containing leukocyte protein of 76 kD.
Received:
January 21 2005
Accepted:
June 01 2005
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2005
J Cell Biol (2005) 170 (1): 115–126.
Article history
Received:
January 21 2005
Accepted:
June 01 2005
Connected Content
Citation
Keigo Nishida, Satoru Yamasaki, Yukitaka Ito, Koki Kabu, Kotaro Hattori, Tohru Tezuka, Hirofumi Nishizumi, Daisuke Kitamura, Ryo Goitsuka, Raif S. Geha, Tadashi Yamamoto, Takeshi Yagi, Toshio Hirano; FcεRI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane . J Cell Biol 4 July 2005; 170 (1): 115–126. doi: https://doi.org/10.1083/jcb.200501111
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
